A major pharmaceutical MNC urgently required the implementation of a compliance system. The local Indian subsidiary was under pressure by its German parent to act swiftly.


The Mumbai-based subsidiary urgently needed to institute a statutory compliance framework in preparation for a global audit by the European parent.
The key deliverables tasked to the WIL Group were:

  • Review local Statutory Compliance framework vs. the parent company’s policies.
  • Define Compliance Checklist to pre-empt violations.
  • Recommend process for efficient handling of compliance violation investigation and preventive mechanism.
  • Develop and recommend Risk Matrix.


X-PM supported by the WIL Group set up a multi-functional team comprising of a finance manager and a legal professional to review the local statutory compliance environment and benchmark it with the parent company’s compliance framework.

The team interviewed various stakeholders within the organization to understand complexities and challenges, reviewed existing company policies, identified applicable local laws and developed a preventive and investigative mechanism to manage compliance violations.


The WIL Group team structured a comprehensive compliance framework for the company within three months.

The final report included the compliance structure, a process for handling and mitigating compliance violations and a Risk Matrix for the company.
The recommended compliance framework adopted by the company successfully cleared the global audit by the European parent and was institutionalized by the local subsidiary